Table 1.
Baseline demographic and laboratory parameters of study infants.
| Age group | 16-week old | 8-week old | 1-week old | |||
|---|---|---|---|---|---|---|
| Randomized group | Vaccine (n = 15) | Control (n = 5) | Vaccine (n = 15) | Control (n = 5) | Vaccine (n = 15) | Control (n = 10) |
| Sex (female) | 7 (47.7%) | 3 (60.0%) | 9 (60.0%) | 2 (40.0%) | 12 (80.0%) | 3 (30.0%) |
| Median (IQR) | Median (IQR) | Median (IQR) | ||||
| Hemoglobin (g/dl) | 10.9 (10.1–12) | 10.4 (10.3–10.7) | 11.6 (10.9–13) | 11.5 (10.8–11.8) | 19.1 (16.8–20.4) | 18.45 (16.5–20.9) |
| White cell count (×109/l) | 8.4 (7.8–9.3) | 10.9 (8.7–14.3) | 10.4 (8.7–13.6) | 7.4 (6.8–11.2) | 18 (13–19.8) | 14.95 (13.9–17) |
| Neutrophil count (×109/l) | 1.9 (1.2–2.7) | 1.4 (0.8–2.3) | 3.4 (2.9–5.2) | 1.6 (1.4–3.6) | 10.8 (6.8–13.3) | 5.1 (4.2–9.4) |
| Lymphocyte count (×109/l) | 5.5 (4.4–6.5) | 7.7 (6.0–10.4) | 5.7 (4.2–8.2) | 4.9 (4.4–8.4) | 5.4 (3.8–5.3) | 7.0 (5.0–10.2) |
| Platelet count (×109/l) | 403 (282–559) | 591 (552–667) | 295 (250–389) | 271 (255–272) | 185 (158–233) | 136.5 (108–239) |
| Alanine transaminase (ALT) (μmol/l) | 26 (17–32) | 24 (24–26) | 18 (15–25) | 21 (20–33) | 21 (16–29) | 19.5 (14–25) |
| Creatinine (U/l) | 11 (10–15) | 13 (13–14) | 21 (18–23) | 21 (19–21) | 55 (51–57) | 53.5 (43–64) |